Patent assignee · US · COMPANY

Sequoia Sciences, Inc.

15Patents
14Active
15Granted
48Portfolio score

Filing activity: Mar 21, 2005 → Apr 8, 2018 · 2 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7612045B2 Compounds, compositions and methods for controlling biofilms and bacterial infections Chemistry; Metallurgy 25 Active
US7604978B2 Inhibition of biofilm formation Emerging Cross-Sectional Technologies 17 Expired
US8324264B1 Inhibitors of bacterial biofilms and related methods Chemistry; Metallurgy 15 Active
US9149522B2 Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections Emerging Cross-Sectional Technologies 10 Active
US9504743B2 Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections Emerging Cross-Sectional Technologies 7 Active
US9415097B2 Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections Emerging Cross-Sectional Technologies 7 Active
US9017698B2 Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections Emerging Cross-Sectional Technologies 7 Active
US9149521B2 Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections Emerging Cross-Sectional Technologies 7 Active
US9415101B2 Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections Emerging Cross-Sectional Technologies 7 Active
US9492522B2 Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections Emerging Cross-Sectional Technologies 1 Active
US9878037B2 Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections Emerging Cross-Sectional Technologies 1 Active
US10137192B2 Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections Emerging Cross-Sectional Technologies 1 Active
US10058608B2 Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections Emerging Cross-Sectional Technologies 0 Active
US9562031B1 Phenethyldihydrobenzodioxolones and methods of use Chemistry; Metallurgy 0 Active
US7367933B2 Screening of chemical compounds purified from biological sources Physics 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.